European Hematology Association (EHA) Congress 2026

The European Hematology Association (EHA) Congress 2026 presents current advances in hematologic malignancies, benign blood disorders, and innovative diagnostic and therapeutic strategies in translational and clinical hematology.

Key Topics

• Gene therapy, cellular immunotherapy and vaccination in biology and clinical practice
• Chronic myeloid leukemia in translational and clinical research
• Quality of life, ethics, supportive and palliative care
• Iron metabolism, deficiency and overload
• Myeloproliferative neoplasms in biology and clinical management
• Acute myeloid leukemia in translational and clinical fields
• Transfusion medicine
• Hematopoiesis, stem cells and bone marrow microenvironment
• Indolent and mantle-cell non-Hodgkin lymphoma in clinical care
• Health economics in hematology
• Platelet disorders
• Chronic lymphocytic leukemia and related disorders in research and treatment
• Infections in hematology and supportive therapy
• Stem cell transplantation in experimental and clinical settings
• Thrombosis and vascular biology
• Myelodysplastic syndromes in biology and patient management
• Acute lymphoblastic leukemia in translational and clinical research
• Enzymopathies, membranopathies and other red blood cell disorders
• Novel technologies, advanced techniques and digital analytical tools in hematology
• Myeloma and other monoclonal gammopathies in research and care
• Bleeding disorders, congenital and acquired
• Hodgkin lymphoma in clinical practice
• Bone marrow failure syndromes including PNH in research and treatment
• Large B cell lymphomas in clinical management
• Sickle cell disease
• Other aggressive lymphomas
• Lymphoma biology and translational research
• Thalassemias

Who should Attend

• Hematologists and hemato-oncologists
• Clinical researchers and translational scientists
• Oncology nurses and allied health professionals
• Laboratory specialists and pathologists
• Transfusion medicine experts
• Stem cell transplantation teams
• Pharmaceutical and biotechnology professionals
• Health economists and policy makers in healthcare
• Medical residents and fellows in hematology
• Professionals involved in supportive and palliative care